ABOUT US
关于我们
As a leading international institution specializing in regenerative medicine and fascia therapy, we are committed to enhancing quality of life and delaying aging through innovative medical technology. Our mission is science-based, aiming to help every client achieve the goal of health and longevity. Through advanced cell therapy and fascia treatments, we provide personalized health management solutions to clients worldwide, helping them restore vitality and embrace a high-quality life.
Zhong Nanshan
Academician
A renowned Chinese respiratory disease expert, committed to research in regenerative medicine, particularly in its applications in immunity and anti-aging.
Zheng Shusen
Academician
A senior surgeon and authority in organ transplantation and regenerative medicine, leading multiple clinical applications of stem cell technologies.
Zeng Yan
Doctor
An expert in regenerative medicine, specializing in research and clinical translation of cell therapy and anti-aging technologies.
Zhang Jianbai
Doctor
A pioneer in stem cell therapy and precision medicine, involved in several innovative studies in regenerative medicine.
Bai Yu
Professor
An internationally recognized expert in fascia therapy, skilled in integrating both Western and Chinese medical techniques to help patients improve chronic pain and bodily functions.
Li Xiaoying
Doctor
A senior gynecology expert who has provided medical services to national leaders. She has extensive experience in women’s reproductive health, anti-aging, and regenerative medicine.
Shaozhen Chen
Doctor
has 16 years of experience in cellular breast augmentation, specializing in autologous fat-derived stem cell regeneration for safe, natural, and long-lasting results, trusted by many.
Our Partners
To ensure we provide the most cutting-edge medical technologies and services, we have established strategic partnerships with several world-class medical institutions. These collaborations allow us to integrate global medical resources, offering innovative and personalized treatment solutions to our clients.
Omotesando Helene Clinic, Japan
Provides world-leading stem cell therapy services.
Cytopeutics, Malaysia
A leading institution in regenerative medicine research and clinical applications, specializing in stem cell therapy.
Mlio Regenerative Center, Shenzhen
An innovative institution in China’s regenerative medicine field, focused on anti-aging and regenerative treatment technologies.
International Private Doctors Alliance
We work closely with the International Private Doctors Alliance, which brings together top medical experts and private doctors worldwide. Dedicated to providing personalized medical solutions for high-end clients, this partnership enables us to offer cross-border medical resources, ensuring the highest quality of medical services globally. The support of this alliance allows us to deliver more comprehensive and professional health management and medical services to our clients.
Jeffrey A. Meyerhardt
Eric P. Winer
Christopher (Jerry) G. Azzoli
Our Journey
Since our establishment, we have been committed to the innovation and development of regenerative medicine technologies. From a small research institution to a globally influential medical organization, every milestone reflects our relentless pursuit of medical science.
- 2010
-
Established the first regenerative medicine research center, focusing on cell therapy and fascia therapy research.
- 2013
-
Began preparations for the National Tissue Engineering Seed Cell Bank.
The National Tissue Engineering Seed Cell Bank (referred to as the "National Bank") is the highest-level national seed cell bank in China, planned under the 12th Five-Year Project by the Ministry of Science and Technology. It is a joint effort with institutions such as the General Hospital of the PLA, the Chinese Academy of Sciences Institute of Genetics and Developmental Biology, Tsinghua University, and Peking University. The National Bank is responsible for the preservation of stem cells and other cell resources, cell application research, the development of stem cell and tissue engineering organ products, and clinical transplantation. It serves as a cell supply institution adhering to national standards.
- 2015
-
Successfully launched the world's first stem cell-based anti-aging therapy, helping clients delay aging and improve their quality of life.
- 2020
-
Partnered with top medical institutions in Japan and Malaysia to provide high-end cross-border medical services to global clients.
- 2021
-
Became the only institution in China authorized as the South China branch of the national-level public tissue engineering seed cell bank, holding the sole authorization for cell therapy in China.
- Patent Info
-
- China: Patent No. 503678
- Germany: Patent No. DE Il 20505(0)
- Europe: Patent No. EP 1381387 B(0)
- International: Patent No. W002087612(A2)
- Japan: Patent No. JP2004526795(T)
- United States: Patent No. US2004082065(A1)